News

September 24th, 2018 Natixis Partners acted as sole advisor to Atrya Group, owned by Mr. Johannes Tryba, on the disposal of its subsidiary Soprofen, active in the manufacturing of rolling shutters and garage doors, to Bouyer Leroux Group

Founded in 1984 by Atrya Group (one of the European leaders in the manufacturing of windows), Soprofen is the third leading player in the conception and manufacturing of residential rolling shutters and garage doors in France, through a wide range of solutions used mainly in existing construction but also in new construction.

The company successfully operates a multichannel distribution strategy relying on c. 3,000 installers, more than 400 industrial carpenters and large B2B / B2C retailers.

Soprofen employs more than 400 people over 9 sites located in France and Belgium, and expects to reach c. €120m of net sales in 2018.

Since the acquisition of Imerys Structure in 2013, Bouyer Leroux is the French leading player in the manufacturing of clay bricks. The acquisition of Soprofen will allow the Bouyer Leroux Group together with its dedicated subsidiaries active in the rolling shutter and garage door market (SPPF and FLO) to enlarge its product offering and become the French co-leader on this market.

‹ Back to news

M&A team:

bruno stern
managing partner

jérôme vivien
executive director

antoine boissoudy (de)
director

guillaume repaire (du)
associate